retatrutide mechanism triple agonist gip glp-1 glucagon Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight The data just dropped —
Description
You should not change your dosing regimen or stop taking Saxenda (liraglutide) as prescribed without discussing with your provider first
But they had limitations: short timelines, selective populations, and controlled conditions
Diabetes and Your Heart
Rubino DM, Greenway FL, Khalid U, et al
